(BCACP) Board Certified Ambulatory Care Pharmacist Exam FREE BCACP Cardiovascular Risk Reduction Questions and Answers
A 65-year-old male with established coronary artery disease is managed with atorvastatin 80 mg daily. His recent lipid panel shows an LDL-C of 65 mg/dL, HDL-C of 40 mg/dL, and triglycerides of 250 mg/dL. According to the results of the REDUCE-IT trial, which agent is most appropriate to add to further reduce this patient's cardiovascular risk?